{"id":1244,"date":"2011-10-13T10:00:00","date_gmt":"2011-10-13T10:00:00","guid":{"rendered":"http:\/\/www.emlitofnote.com\/?p=1244"},"modified":"2016-08-01T08:59:00","modified_gmt":"2016-08-01T15:59:00","slug":"high-sensitivity-troponin-for-better-or-worse","status":"publish","type":"post","link":"https:\/\/www.emlitofnote.com\/?p=1244","title":{"rendered":"High-Sensitivity Troponin For Better Or Worse"},"content":{"rendered":"<div>The premise of this article seems fine &#8211; as we all learned in medical school, the <strike>LDH<\/strike> <strike>CK-MB<\/strike> Troponin is now our most sensitive and specific assay for myocardial injury, but, we were also taught that it takes a certain amount of time for the assay to turn positive.&nbsp; Thus, the inpatient rule-out with multiple sets of cardiac enzymes.&nbsp; These investigators looked a new assay, with a lower detection limit, and hope to prove that it has 100% sensitivity with a single measurement, obviating the need for additional enzymatic testing.<\/div>\n<div><\/div>\n<div>There were two phases &#8211; a cohort observational portion and a clinical deployment portion.&nbsp; The observational phase was intended to verify prior data suggesting 99% sensitivity for the assay and, of their 703 patients, 195 had initial hs-cTnT levels of &lt;3ng\/L &#8211; and none had acute MI in their 6 month follow-up period (97.8 to 100% sensitivity).&nbsp; In their clinical deployment phase, they collected 915 patients who received two sets of the hs-cTnT assay, and found that only one patient had a subsequent hs-cTnT rise after an initially undetectable hs-cTnT, giving a sensitivity of 99.8% (99.1-100).<\/div>\n<div><\/div>\n<div>So, they say, there is no longer any realistic need to get multiple sets of cardiac enzymes in a patient if the first level is undetectable.&nbsp; This is probably true, but whether it reduces inpatient stays and follow-up invasive cardiac testing is another matter.&nbsp; My guess is that widespread availability of this assay would lead to clinicians ordering troponins on patients they wouldn&#8217;t have previously ordered them on, and &#8211; perhaps you know how this story will probably play out &#8211; a story in which use of the d-Dimer assay would decrease chest imaging for pulmonary embolism, but didn&#8217;t.&nbsp; Too many clinicians are applying it incorrectly and using its weak positive likelihood ratio to light up patients unnecessarily, and I expect this to lead to more patients being kept for testing, not fewer, as the authors propose.<\/div>\n<p>&#8220;Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable Troponin Using a High-Sensitivity Assay&#8221;<br \/><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21920261\">www.ncbi.nlm.nih.gov\/pubmed\/21920261<\/a><\/p>\n\n<div class=\"twitter-share\"><a href=\"https:\/\/twitter.com\/intent\/tweet?via=emlitofnote\" class=\"twitter-share-button\">Tweet<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The premise of this article seems fine &#8211; as we all learned in medical school, the LDH CK-MB Troponin is now our most sensitive and specific assay for myocardial injury, but, we were also taught that it takes a certain amount of time for the assay to turn positive.&nbsp; Thus, the inpatient rule-out with multiple &hellip; <a href=\"https:\/\/www.emlitofnote.com\/?p=1244\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;High-Sensitivity Troponin For Better Or Worse&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-1244","post","type-post","status-publish","format-standard","hentry","category-cardiology"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7KesJ-k4","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/posts\/1244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1244"}],"version-history":[{"count":1,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/posts\/1244\/revisions"}],"predecessor-version":[{"id":2963,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=\/wp\/v2\/posts\/1244\/revisions\/2963"}],"wp:attachment":[{"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emlitofnote.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}